The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Romiplostim Market Research Report 2025
Synopsis
Romiplostim (rINN, USAN) is a fusion protein analog of thrombopoietin, a hormone that regulates platelet production.
The global Romiplostim market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Romiplostim is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Romiplostim is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Romiplostim in Adults is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Romiplostim include AMGEN. etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Romiplostim, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Romiplostim.
Report Scope
The Romiplostim market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Romiplostim market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Romiplostim companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AMGEN
Segment by Type
250 μg/0.5 mL
500 μg/1 mL
Segment by Application
Adults
Pediatric patients
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Romiplostim companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Romiplostim (rINN, USAN) is a fusion protein analog of thrombopoietin, a hormone that regulates platelet production.
The global Romiplostim market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Romiplostim is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Romiplostim is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Romiplostim in Adults is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Romiplostim include AMGEN. etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Romiplostim, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Romiplostim.
Report Scope
The Romiplostim market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Romiplostim market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Romiplostim companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AMGEN
Segment by Type
250 μg/0.5 mL
500 μg/1 mL
Segment by Application
Adults
Pediatric patients
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Romiplostim companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Romiplostim Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 250 μg/0.5 mL
1.2.3 500 μg/1 mL
1.3 Market by Application
1.3.1 Global Romiplostim Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Adults
1.3.3 Pediatric patients
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Romiplostim Market Perspective (2019-2030)
2.2 Romiplostim Growth Trends by Region
2.2.1 Global Romiplostim Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Romiplostim Historic Market Size by Region (2019-2024)
2.2.3 Romiplostim Forecasted Market Size by Region (2025-2030)
2.3 Romiplostim Market Dynamics
2.3.1 Romiplostim Industry Trends
2.3.2 Romiplostim Market Drivers
2.3.3 Romiplostim Market Challenges
2.3.4 Romiplostim Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Romiplostim Players by Revenue
3.1.1 Global Top Romiplostim Players by Revenue (2019-2024)
3.1.2 Global Romiplostim Revenue Market Share by Players (2019-2024)
3.2 Global Romiplostim Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Romiplostim Revenue
3.4 Global Romiplostim Market Concentration Ratio
3.4.1 Global Romiplostim Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Romiplostim Revenue in 2023
3.5 Romiplostim Key Players Head office and Area Served
3.6 Key Players Romiplostim Product Solution and Service
3.7 Date of Enter into Romiplostim Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Romiplostim Breakdown Data by Type
4.1 Global Romiplostim Historic Market Size by Type (2019-2024)
4.2 Global Romiplostim Forecasted Market Size by Type (2025-2030)
5 Romiplostim Breakdown Data by Application
5.1 Global Romiplostim Historic Market Size by Application (2019-2024)
5.2 Global Romiplostim Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Romiplostim Market Size (2019-2030)
6.2 North America Romiplostim Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Romiplostim Market Size by Country (2019-2024)
6.4 North America Romiplostim Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Romiplostim Market Size (2019-2030)
7.2 Europe Romiplostim Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Romiplostim Market Size by Country (2019-2024)
7.4 Europe Romiplostim Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Romiplostim Market Size (2019-2030)
8.2 Asia-Pacific Romiplostim Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Romiplostim Market Size by Region (2019-2024)
8.4 Asia-Pacific Romiplostim Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Romiplostim Market Size (2019-2030)
9.2 Latin America Romiplostim Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Romiplostim Market Size by Country (2019-2024)
9.4 Latin America Romiplostim Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Romiplostim Market Size (2019-2030)
10.2 Middle East & Africa Romiplostim Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Romiplostim Market Size by Country (2019-2024)
10.4 Middle East & Africa Romiplostim Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AMGEN
11.1.1 AMGEN Company Detail
11.1.2 AMGEN Business Overview
11.1.3 AMGEN Romiplostim Introduction
11.1.4 AMGEN Revenue in Romiplostim Business (2019-2024)
11.1.5 AMGEN Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Romiplostim Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of 250 μg/0.5 mL
Table 3. Key Players of 500 μg/1 mL
Table 4. Global Romiplostim Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Romiplostim Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Romiplostim Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Romiplostim Market Share by Region (2019-2024)
Table 8. Global Romiplostim Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Romiplostim Market Share by Region (2025-2030)
Table 10. Romiplostim Market Trends
Table 11. Romiplostim Market Drivers
Table 12. Romiplostim Market Challenges
Table 13. Romiplostim Market Restraints
Table 14. Global Romiplostim Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Romiplostim Market Share by Players (2019-2024)
Table 16. Global Top Romiplostim Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Romiplostim as of 2023)
Table 17. Ranking of Global Top Romiplostim Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Romiplostim Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Romiplostim Product Solution and Service
Table 21. Date of Enter into Romiplostim Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Romiplostim Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Romiplostim Revenue Market Share by Type (2019-2024)
Table 25. Global Romiplostim Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Romiplostim Revenue Market Share by Type (2025-2030)
Table 27. Global Romiplostim Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Romiplostim Revenue Market Share by Application (2019-2024)
Table 29. Global Romiplostim Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Romiplostim Revenue Market Share by Application (2025-2030)
Table 31. North America Romiplostim Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Romiplostim Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Romiplostim Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Romiplostim Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Romiplostim Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Romiplostim Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Romiplostim Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Romiplostim Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Romiplostim Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Romiplostim Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Romiplostim Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Romiplostim Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Romiplostim Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Romiplostim Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Romiplostim Market Size by Country (2025-2030) & (US$ Million)
Table 46. AMGEN Company Detail
Table 47. AMGEN Business Overview
Table 48. AMGEN Romiplostim Product
Table 49. AMGEN Revenue in Romiplostim Business (2019-2024) & (US$ Million)
Table 50. AMGEN Recent Development
Table 51. Research Programs/Design for This Report
Table 52. Key Data Information from Secondary Sources
Table 53. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Romiplostim Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Romiplostim Market Share by Type: 2023 VS 2030
Figure 3. 250 μg/0.5 mL Features
Figure 4. 500 μg/1 mL Features
Figure 5. Global Romiplostim Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Romiplostim Market Share by Application: 2023 VS 2030
Figure 7. Adults Case Studies
Figure 8. Pediatric patients Case Studies
Figure 9. Romiplostim Report Years Considered
Figure 10. Global Romiplostim Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 11. Global Romiplostim Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Romiplostim Market Share by Region: 2023 VS 2030
Figure 13. Global Romiplostim Market Share by Players in 2023
Figure 14. Global Top Romiplostim Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Romiplostim as of 2023)
Figure 15. The Top 10 and 5 Players Market Share by Romiplostim Revenue in 2023
Figure 16. North America Romiplostim Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 17. North America Romiplostim Market Share by Country (2019-2030)
Figure 18. United States Romiplostim Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. Canada Romiplostim Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Europe Romiplostim Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe Romiplostim Market Share by Country (2019-2030)
Figure 22. Germany Romiplostim Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. France Romiplostim Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. U.K. Romiplostim Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Italy Romiplostim Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Russia Romiplostim Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Nordic Countries Romiplostim Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Asia-Pacific Romiplostim Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific Romiplostim Market Share by Region (2019-2030)
Figure 30. China Romiplostim Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Japan Romiplostim Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. South Korea Romiplostim Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Southeast Asia Romiplostim Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. India Romiplostim Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Australia Romiplostim Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Latin America Romiplostim Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America Romiplostim Market Share by Country (2019-2030)
Figure 38. Mexico Romiplostim Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Brazil Romiplostim Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Middle East & Africa Romiplostim Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa Romiplostim Market Share by Country (2019-2030)
Figure 42. Turkey Romiplostim Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Saudi Arabia Romiplostim Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. AMGEN Revenue Growth Rate in Romiplostim Business (2019-2024)
Figure 45. Bottom-up and Top-down Approaches for This Report
Figure 46. Data Triangulation
Figure 47. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
